Page last updated: 2024-09-05

ramelteon and Adverse Drug Event

ramelteon has been researched along with Adverse Drug Event in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Lehmann, R; Mayer, G; Partinen, M; Roth-Schechter, B; Staner, C; Wang-Weigand, S	1
Gilbert, M; Laustsen, G; Wimett, L	1
Hussar, DA	1

Trials

1 trial(s) available for ramelteon and Adverse Drug Event

Article	Year
Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep, 2009, Volume: 32, Issue:3 Topics: Adolescent; Adult; Aged; Attention; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Memory, Short-Term; Middle Aged; Polysomnography; Prospective Studies; Retention, Psychology; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Wakefulness; Young Adult	2009

Article

Year

Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Sleep, 2009, Volume: 32, Issue:3

Topics: Adolescent; Adult; Aged; Attention; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Memory, Short-Term; Middle Aged; Polysomnography; Prospective Studies; Retention, Psychology; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Wakefulness; Young Adult

2009

Other Studies

3 other study(ies) available for ramelteon and Adverse Drug Event

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
A look back at the most influential drug approvals of 2005. The Nurse practitioner, 2006, Volume: 31, Issue:2 Topics: Amyloid; Analgesics; Anticonvulsants; Antiparkinson Agents; Diabetes Mellitus, Type 2; Diphtheria-Tetanus-Pertussis Vaccine; Drug Approval; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Exenatide; gamma-Aminobutyric Acid; Heart Failure; Humans; Hydralazine; Hypoglycemic Agents; Indenes; Indoles; Islet Amyloid Polypeptide; Isosorbide Dinitrate; Patient Education as Topic; Patient Selection; Peptides; Pregabalin; Sleep Wake Disorders; United States; United States Food and Drug Administration; Venoms	2006
New drugs 06, part II. Nursing, 2006, Volume: 36, Issue:8 Topics: Analgesics; Benzeneacetamides; Benzoates; Bone Density Conservation Agents; Deferasirox; Diphosphonates; Docosahexaenoic Acids; Drug Approval; Drug Combinations; Drug Interactions; Drug Monitoring; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Eicosapentaenoic Acid; gamma-Aminobutyric Acid; Humans; Ibandronic Acid; Iloprost; Indenes; Minocycline; Patient Education as Topic; Phenylacetates; Pregabalin; Tigecycline; Triazoles; Vasodilator Agents	2006